Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial

Show other versions (2)
Bibliographic Details
Main Authors: Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A
Format: Conference item
Published: 2010

Similar Items